SCHEMBL13443588

SCHEMBL13443588

CC1(C)c2cc(-c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4ccccn4)c4ccccc34)ccc2-c2ccc(-c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4ccccn4)c4ccccc34)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ PDK2 Q15119 1/20 0.33
▸ GRM4 Q14833 1/20 0.32
▸ MEN1 O00255 4/20 0.32
▸ KMT2A Q03164 4/20 0.32
▸ MAT2A P31153 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ LMNA P02545 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ UHRF1 Q96T88 1/20 0.31
▸ FFAR4 Q5NUL3 2/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ACVR1 Q04771 1/20 0.31
▸ BRD4 O60885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13443614 0.96 NPY5R (0.38) NPY5RALDH1A1PDK2MEN1KMT2A
SCHEMBL13443581 0.95 NPY5R (0.37) NPY5RALDH1A1PDK2MEN1KMT2A
SCHEMBL13443602 0.92 NPY5R (0.37) NPY5RALDH1A1PDK2MEN1KMT2A
SCHEMBL13443620 0.90 NPY5R (0.34) NPY5RALDH1A1PDK2KDM4EMAPT
SCHEMBL13443689 0.90 PDK2 (0.34) NPY5RALDH1A1PDK2MEN1KMT2A
SCHEMBL13443772 0.89 NPY5R (0.34) NPY5RALDH1A1MEN1KMT2ALMNA
SCHEMBL12111085 0.87 ALDH1A1 (0.33) NPY5RALDH1A1PDK2FFAR4
SCHEMBL13443656 0.87 PDK2 (0.37) NPY5RALDH1A1PDK2GRM4MEN1
SCHEMBL13443750 0.87 ALDH1A1 (0.32) ALDH1A1KDM4EACVR1
SCHEMBL12109612 0.86 ALDH1A1 (0.33) NPY5RALDH1A1PDK2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100066241-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-18 — — US disclosed
US-20100066241-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100066241-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same IL33, ORMDL3, CCND3 NPY5R 637/4885ALDH1A1 1298/4885PDK2 3177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback